The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

Morning! Today, we hear that Pfizer CEO Albert Bourla spoke plainly at a WSJ Davos event about his distaste for health secretary RFK Jr.’s vaccine policy, see CEPI and Merck fund a more scalable Ebola ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Syracuse, NY — Upstate Medical University is looking for 1,000 volunteers — its largest clinical trial to date — to test a ...

Scientists have developed a new nanoparticle-based strategy that could dramatically expand the range of disease-causing proteins that can be targeted by modern medicine. A newly released perspective i ...

Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...

The unprecedented changes have led to diminished vaccine usage, and created a drag that will likely dent revenues.

After U.S. President Donald Trump took the stage at the World Economic Forum this week to tout the supposed success of his ...

Ken Paxton launches an investigation into alleged financial incentives behind childhood vaccine recommendations.

Bristol Myers Squibb BMY highlighted the potential of its deep and promising pipeline at the 44th Annual J.P. Morgan ...

Meanwhile, an anti-vaccine group filed a racketeering lawsuit against a top medical societ ...